TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. [electronic resource]
- Journal of cellular physiology 08 2018
- 5838-5846 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-4652
10.1002/jcp.26373 doi
Adolescent Adult Aged Aged, 80 and over Biomarkers, Tumor--biosynthesis Child DNA-Binding Proteins--biosynthesis Dioxygenases Down-Regulation--genetics Female Gene Expression Regulation, Leukemic--genetics Humans Leukemia, Myeloid, Acute--genetics Male Middle Aged Nucleophosmin Proto-Oncogene Proteins--biosynthesis RNA, Messenger--genetics Young Adult